Mitizodone (developmental code name HEC-113995) is a serotonin reuptake inhibitor and serotonin 5-HT1A receptor partial agonist which is under development for the treatment of major depressive disorder.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.